Circulating biomarkers of response to immunotherapy in cancer treatment

Pharmacogenomics. 2019 Dec;20(18):1247-1249. doi: 10.2217/pgs-2019-0117. Epub 2019 Nov 6.

Authors

Marzia Del Re¹, Giulia Gianfilippo¹, Stefania Crucitta¹, Alfredo Addeo², Ron Hn van Schaik³, Romano Danesi¹

Affiliations

¹ Unit of Clinical Pharmacology & Pharmacogenetics, Department of Clinical & Experimental Medicine, University Hospital of Pisa, 56126, Italy.
² Oncology Department, University Hospital Geneva, Geneva 1205, Switzerland.
³ Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, South Holland 3015, The Netherlands.

PMID: 31691637
DOI: 10.2217/pgs-2019-0117

No abstract available

Keywords: circulating biomarkers; immunotherapy; predictive biomarkers; solid tumors.

Publication types

Editorial

MeSH terms

Biomarkers, Tumor / blood*
Humans
Immunotherapy*
Neoplasms / blood
Neoplasms / immunology
Neoplasms / therapy*
Neoplastic Cells, Circulating*

Substances

Biomarkers, Tumor